Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway.

Similar Items

• Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies
  by: Mohammed S. Taghour, et al.
  Published: (2022-12-01)
• Discovery of new thiazolidine-2,4-dione derivatives as potential VEGFR-2 inhibitors: In vitro and in silico studies
  by: Ibrahim H. Eissa, et al.
  Published: (2024-01-01)
• New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies
  by: Eslam B. Elkaeed, et al.
  Published: (2022-12-01)
• Design and In Silico and In Vitro Evaluations of a Novel Nicotinamide Derivative as a VEGFR-2 Inhibitor
  by: Ibrahim H. Eissa, et al.
  Published: (2024-01-01)
• Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects
  by: Eslam B. Elkaeed, et al.
  Published: (2022-07-01)